Fineline Cube

Follow:
14455 Articles
CompanyDrug

Ascentage Pharma’s Olverembatinib Gets NMPA Greenlight for Phase III Study in Ph+ ALL

CompanyDrug

Amoytop Biotech’s Pegfilgrastim (Y Shape) Approved for Marketing by NMPA

CompanyDeals

Jacobio Pharma Retakes Global Rights to SHP2 Inhibitors After Terminating AbbVie Agreement

CompanyMedical Device

Helio Genomics’ Sister Company LAMH Wins NMPA Approval for Liver Cancer Test in China

Policy / Regulatory

NHSA Unveils Updated National Reimbursement Drug List Rules for 2023

CompanyDeals

Binhui Biopharmaceutical and Topgene Biotechnology Partner for New Drug R&D and AI Platform Development

CompanyDrug

Huadong Medicine’s Mirvetuximab Soravtansine Heads for Priority Review by China’s CDE

Policy / Regulatory

NMPA Proposes Revisions to “Drug Inspection Management Measures”, Seeks Public Feedback

Company

Henlius Biotech Suspends IPO on STAR Market, Aims to Optimize Capital Strategy

CompanyDeals

Shanghai’s Huangpu District Launches RMB Fund to Boost Fintech, AI, and Biotech Firms

CompanyDrug

Transcenta’s Osemitamab Combo Shows Promising PFS Data in Advanced GC/GEJ Cancer Study

CompanyDrug

Hybio Pharmaceutical’s Liraglutide Biosimilar Withdrawn from NMPA Filing